A novel prokaryotic L-arginine:glycine amidinotransferase is involved in cylindrospermopsin biosynthesis

被引:54
|
作者
Muenchhoff, Julia [1 ]
Siddiqui, Khawar S. [1 ]
Poljak, Anne [2 ,3 ]
Raftery, Mark J. [2 ,3 ]
Barrow, Kevin D. [1 ]
Neilan, Brett A. [1 ]
机构
[1] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia
基金
澳大利亚研究理事会;
关键词
amidinotransferase; cyanobacterial toxin; enzyme kinetics; protein stability; toxin biosynthesis; CYANOBACTERIAL ALKALOID CYLINDROSPERMOPSIN; GLYCINE AMIDINOTRANSFERASE; 1ST REPORT; REACTION-MECHANISM; GENE-CLUSTER; HOG KIDNEY; RACIBORSKII; ACID; TRANSAMIDINASE; IDENTIFICATION;
D O I
10.1111/j.1742-4658.2010.07788.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the first characterization of an l-arginine:glycine amidinotransferase from a prokaryote. The enzyme, CyrA, is involved in the pathway for biosynthesis of the polyketide-derived hepatotoxin cylindrospermopsin from Cylindrospermopsis raciborskii AWT205. CyrA is phylogenetically distinct from other amidinotransferases, and structural alignment shows differences between the active site residues of CyrA and the well-characterized human l-arginine:glycine amidinotransferase (AGAT). Overexpression of recombinant CyrA in Escherichia coli enabled biochemical characterization of the enzyme, and we confirmed the predicted function of CyrA as an l-arginine:glycine amidinotransferase by 1H NMR. As compared with AGAT, CyrA showed narrow substrate specificity when presented with substrate analogs, and deviated from regular Michaelis-Menten kinetics in the presence of the non-natural substrate hydroxylamine. Studies of initial reaction velocities and product inhibition, and identification of intermediate reaction products, were used to probe the kinetic mechanism of CyrA, which is best described as a hybrid of ping-pong and sequential mechanisms. Differences in the active site residues of CyrA and AGAT are discussed in relation to the different properties of both enzymes. The enzyme had maximum activity and maximum stability at pH 8.5 and 6.5, respectively, and an optimum temperature of 32 degrees C. Investigations into the stability of the enzyme revealed that an inactivated form of this enzyme retained an appreciable amount of secondary structure elements even on heating to 94 degrees C, but lost its tertiary structure at low temperature (T-max of 44.5 degrees C), resulting in a state reminiscent of a molten globule. CyrA represents a novel group of prokaryotic amidinotransferases that utilize arginine and glycine as substrates with a complex kinetic mechanism and substrate specificity that differs from that of the eukaryotic l-arginine:glycine amidinotransferases.
引用
收藏
页码:3844 / 3860
页数:17
相关论文
共 50 条
  • [21] The ligand-induced structural changes of human L-arginine:glycine amidinotransferase -: A mutational and crystallographic study
    Fritsche, E
    Humm, A
    Huber, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) : 3026 - 3032
  • [22] Association Between Homoarginine and Acute Ischaemic Stroke - The Role of L-Arginine:Glycine-Amidinotransferase (AGAT)
    Atzler, Dorothee
    Choe, Chi-un
    Zeller, Tanja
    Carter, Angela M.
    Schwedhelm, Edzard
    Schillert, Arne
    Lueneburg, Nicole
    Ziegler, Andreas
    Muenzel, Thomas
    Magnus, Tim
    Boeger, Rainer H.
    Blankenberg, Stefan
    Grant, Peter J.
    Isbrandt, Dirk
    CIRCULATION, 2011, 124 (21)
  • [23] THE PRODUCTION AND CHARACTERIZATION OF 2 MONOCLONAL-ANTIBODIES TO RAT-KIDNEY L-ARGININE - GLYCINE AMIDINOTRANSFERASE
    GROSS, MD
    MCGUIRE, DM
    VANPILSUM, JF
    HYBRIDOMA, 1985, 4 (03): : 257 - 269
  • [24] Crystal structure of L-arginine:inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus:: An enzyme involved in streptomycin biosynthesis
    Fritsche, E
    Bergner, A
    Humm, A
    Piepersberg, W
    Huber, R
    BIOCHEMISTRY, 1998, 37 (51) : 17664 - 17672
  • [25] L-arginine: glycine amidinotransferase deficiency protects from metabolic syndrome (vol 22, pg 110, 2013)
    Choe, Chi-un
    Nabuurs, Christine
    Stockebrand, Malte C.
    Neu, Axel
    Nunes, Patricia
    Morellini, Fabio
    Sauter, Kathrin
    Schillemeit, Stefan
    Hermans-Borgmeyer, Irm
    Marescau, Bart
    Heerschap, Arend
    Isbrandt, Dirk
    HUMAN MOLECULAR GENETICS, 2013, 22 (19) : 4030 - 4030
  • [27] Association between L-arginine:glycine-amidinotransferase (AGAT) and homoarginine in humans and genetically modified mice.
    Atzler, D.
    Choe, C. -U
    Ojeda, F.
    Zeller, T.
    Lueneburg, N.
    Marescau, B.
    Boeger, R. H.
    Isbrandt, D.
    Blankenberg, S.
    Schwedhelm, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 77 - 77
  • [28] Homoarginine- and Creatine-Dependent Gene Regulation in Murine Brains with l-Arginine:Glycine Amidinotransferase Deficiency
    Jensen, Marit
    Mueller, Christian
    Schwedhelm, Edzard
    Arunachalam, Priyadharshini
    Gelderblom, Mathias
    Magnus, Tim
    Gerloff, Christian
    Zeller, Tanja
    Choe, Chi-un
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [29] Recombinant expression and isolation of human L-arginine: Glycine amidinotransferase and identification of its active-site cysteine residue
    Humm, A
    Fritsche, E
    Mann, K
    Gohl, M
    Huber, R
    BIOCHEMICAL JOURNAL, 1997, 322 : 771 - 776
  • [30] Diagnostic enzyme assay that uses stable-isotope-labeled substrates to detect L-arginine:glycine amidinotransferase deficiency
    Verhoeven, NM
    Schor, DSM
    Roos, B
    Battini, R
    Stöckler-Ipsiroglu, S
    Salomons, GS
    Jakobs, C
    CLINICAL CHEMISTRY, 2003, 49 (05) : 803 - 805